Novel role of sphingosine kinase 1 as a mediator of neurotrophin-3 action in oligodendrocyte progenitors

J Neurochem. 2005 Dec;95(5):1298-310. doi: 10.1111/j.1471-4159.2005.03451.x.

Abstract

We had found previously that neurotrophin-3 (NT-3) is a potent stimulator of cAMP-response element binding protein (CREB) phosphorylation in cultured oligodendrocyte progenitors. Here, we show that CREB phosphorylation in these cells is also highly stimulated by sphingosine-1-phosphate (S1P), a sphingolipid metabolite that is known to be a potent mediator of numerous biological processes. Moreover, CREB phosphorylation in response to NT-3 involves sphingosine kinase 1 (SphK1), the enzyme that synthesizes S1P. Immunocytochemistry and confocal microscopy indicated that NT-3 induces translocation of SphK1 from the cytoplasm to the plasma membrane of oligodendrocytes, a process accompanied by increased SphK1 activity in the membrane fraction where its substrate sphingosine resides. To examine the involvement of SphK1 in NT-3 function, SphK1 expression was down-regulated by treatment with SphK1 sequence-specific small interfering RNA. Remarkably, the capacity of NT-3 to protect oligodendrocyte progenitors from apoptotic cell death induced by growth factor deprivation was abolished by down-regulating the expression of SphK1, as assessed by terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay. Altogether, these results suggest that SphK1 plays a crucial role in the stimulation of oligodendrocyte progenitor survival by NT-3, and demonstrate a functional link between NT-3 and S1P signaling, adding to the complexity of mechanisms that modulate neurotrophin function and oligodendrocyte development.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Blotting, Western / methods
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism
  • Cells, Cultured
  • Cyclic AMP Response Element-Binding Protein / metabolism
  • Drug Interactions
  • Gene Expression Regulation / drug effects
  • In Situ Nick-End Labeling / methods
  • Lysophospholipids / pharmacology
  • Mitogen-Activated Protein Kinase 3 / metabolism
  • Mitogen-Activated Protein Kinases / metabolism
  • Models, Biological
  • Neurotrophin 3 / pharmacology*
  • Oligodendroglia*
  • Phosphorylation / drug effects
  • Phosphotransferases (Alcohol Group Acceptor) / metabolism*
  • Protein Kinase C / pharmacology
  • RNA, Small Interfering / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Sphingosine / analogs & derivatives
  • Sphingosine / pharmacology
  • Stem Cells / drug effects*
  • Stem Cells / physiology
  • Thiazoles / pharmacology
  • Thiazolidinediones
  • Thiones / pharmacology
  • Time Factors

Substances

  • Cyclic AMP Response Element-Binding Protein
  • Lysophospholipids
  • Neurotrophin 3
  • RNA, Small Interfering
  • Thiazoles
  • Thiazolidinediones
  • Thiones
  • thiazolidine-2,4-thione
  • dihydrosphingosine 1-phosphate
  • sphingosine 1-phosphate
  • Phosphotransferases (Alcohol Group Acceptor)
  • sphingosine kinase
  • Protein Kinase C
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases
  • N,N-dimethylsphingosine
  • Sphingosine